These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23743668)

  • 1. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus.
    Vafadari R; Bouamar R; Hesselink DA; Kraaijeveld R; van Schaik RH; Weimar W; Baan CC; van Gelder T
    Ther Drug Monit; 2013 Aug; 35(4):459-65. PubMed ID: 23743668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.
    Glowacki F; Lionet A; Buob D; Labalette M; Allorge D; Provôt F; Hazzan M; Noël C; Broly F; Cauffiez C
    Nephrol Dial Transplant; 2011 Sep; 26(9):3046-50. PubMed ID: 21677300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
    Akbas SH; Bilgen T; Keser I; Tuncer M; Yucetin L; Tosun O; Gultekin M; Luleci G
    Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
    Singh R; Srivastava A; Kapoor R; Mittal RD
    J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
    Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis.
    Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G
    Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.
    Capron A; Mourad M; De Meyer M; De Pauw L; Eddour DC; Latinne D; Elens L; Haufroid V; Wallemacq P
    Pharmacogenomics; 2010 May; 11(5):703-14. PubMed ID: 20415563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor ABCB1 3435 C>T genetic polymorphisms influence early renal function in kidney transplant recipients treated with tacrolimus.
    Yan L; Li Y; Tang JT; An YF; Wang LL; Shi YY
    Pharmacogenomics; 2016 Feb; 17(3):249-57. PubMed ID: 26784512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
    Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients.
    Bonhomme-Faivre L; Picard V; Saliba F; Abbara C; Fodil M; Chaunoy M; Farinotti R
    Am J Health Syst Pharm; 2009 Sep; 66(18):1645-51. PubMed ID: 19729569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes.
    Noceti OM; Woillard JB; Boumediene A; Esperón P; Taupin JL; Gerona S; Valverde M; Touriño C; Marquet P
    Clin Chem; 2014 Oct; 60(10):1336-45. PubMed ID: 25142246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
    Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
    Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.
    Jordán de Luna C; Herrero Cervera MJ; Sánchez Lázaro I; Almenar Bonet L; Poveda Andrés JL; Aliño Pellicer SF
    Transplant Proc; 2011; 43(6):2241-3. PubMed ID: 21839244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
    Llaudó I; Colom H; Giménez-Bonafé P; Torras J; Caldés A; Sarrias M; Cruzado JM; Oppenheimer F; Sánchez-Plumed J; Gentil MÁ; Ekberg H; Grinyó JM; Lloberas N
    Transpl Int; 2013 Feb; 26(2):177-86. PubMed ID: 23216707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
    Li D; Gui R; Li J; Huang Z; Nie X
    Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients.
    Li Y; Hu X; Cai B; Chen J; Bai Y; Tang J; Liao Y; Wang L
    Transpl Immunol; 2012 Aug; 27(1):12-8. PubMed ID: 22504573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients.
    Ciftci HS; Ayna TK; Caliskan YK; Guney I; Bakkaloglu H; Nane I; Aydin AE; Turkmen A; Gurtekin M
    Transplant Proc; 2013 Apr; 45(3):895-900. PubMed ID: 23622581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.
    Riegersperger M; Plischke M; Steinhauser C; Jallitsch-Halper A; Sengoelge G; Winkelmayer WC; Sunder-Plassmann G; Födinger M
    Clin Lab; 2016 Oct; 62(10):1965-1972. PubMed ID: 28164520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms.
    Quaglia M; Terrazzino S; Boldorini R; Stratta P; Genazzani AA
    J Clin Pharm Ther; 2013 Aug; 38(4):333-6. PubMed ID: 23574377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.